Search Results
Results found for "cAM SINH LU"
- Ep 136 with Murat Tunaboylu & Ben Holland
learning for nearly 10 years, applying it to antibody generation, analysis, and property prediction since
- Ep 141 with Dr Tobi Langenhan
Biochemistry and first came across GPCRs, particularly the receptor family I have been investigating ever since
- Explore / Organizations | Dr. GPCR Ecosystem
Post you job description and since this is a closed Ecosystem, you can (if you'd like) share the contact
- Ep 109 with Dr. Katarina Nemec
Since my undergraduate studies, I have been engaged in researching molecular mechanisms that govern human
- Ep 104 with Dr. Raul Gainetdinov
Since 2013, he has been elected Chair of the subcommittee for the Dopamine receptors of the International
- Ep 114 with Dr. Robert F. Bruns
After 7 years at WL/PD and 26 years at Eli Lilly & Co., he retired at the end of 2014 and since then
- Ep 70 with Dr. Stephen Ferguson
He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of
- Ep 48 with Dr Nyla Naim Dr Michael Lemieux Dr Jason Nasse from Addgene
Since then I transitioned into a Scientific Support role to leverage my passion for helping people!
- Distinct sub-cellular signal propagation as a component of functional selectivity
Since 2001, he holds the Canada Research Chair in Signal Transduction and Molecular Pharmacology.
- Ep 84 with Rosie Dawaliby
And since then, my incredible adventure as CEO of this fast-growing company started and is continuing
- About Dr. GPCR Podcast | Dr. GPCR Ecosystem
I hadn't heard a scientific talk outside my lab since February and was starved to hear someone else talk
- Ep 69 with Dr. Stephen Ferguson
He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of
- Plenary Lecture | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
and Hearing and Balance Receptors Abstract Only Available for AGPCR24 Attendees About Jin-Peng Sun "Since
- Ep 142 with Dr Claudia Stäubert
This fascination accompanied me and repeatedly challenged me ever since. Since 2014, I have led a research group at the Rudolf Schönheimer Institute of Biochemistry in Leipzig
- Ep 158 with Dr. Mikel Garcia-Marcos
All my formal training was in the area of signal transduction, and I continued to work on this area since
- Ep 106 with Dr. Bruno Giros
Since 2008, he has arrived at McGill University as a Canada Research Chair.
- Ep 125 with Dr. Gregory Tall
Tall has been continuously funded by the NIH since receiving an early RO1 award at Rochester.
- Ep 147 with Dr. Demet Araç
Demet explained that since the year 2000, the field has seen significant growth, with important discoveries Demet shared that they have been working on the Latrophilin project since 2013, screening about 20 adhesion
- Ep 36 with Dr. Michel Bouvier
Since 2001, he holds the Canada Research Chair in Signal Transduction and Molecular Pharmacology.
- Ep 155 with Endocrine Metabolic GPCR Organizers
Aylin Hanyaloglu has been a Principal Investigator at Imperial College London since 2007.
- Session VIII | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Professional Background Since 2021 Group Leader, Institute for Diabetes and Cancer, Helmholtz Diabetes
- Session IV | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Since then, I have broadened my horizons with many more techniques in vivo and in vitro, with a main
- Posters | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
CELSR1 is reactivated in luminal-type ductal carcinomas. Notably, our pilot data from luminal-type breast cancer cell lines representative of breast carcinomas specific hypothesis that biased expression of CELSR1 isoforms will predict invasive potential of a luminal tumour invasive mechanism (b) quantify CELSR1 isoform expression (mRNA and protein) within patient luminal Since staring my postdoctoral training, I have continued to develop my expertise to answer fundamental
- Flash News: Your Hub for GPCR Insights and Scientific Conference Programs
to control target engagement—so duration, penetration, and PK/PD separation serve your program, not sink It wasn’t luck.
- Ep 140 with Dr Alix A J Rouault
Since I joined the lab, I became proficient in many In-vivo techniques, I adapted my arrestin recruitment
- Dr. GPCR Summit 2021 | Dr. GPCR Ecosystem
Pros: It may take less time to prepare for the presentation Cons: You may make mistakes since it's a
- Ep 153 with Dr Jacek Mokrosiński
Since 2021, Jacek has been working at Novo Nordisk at its research sites in the UK (Oxford) and the US
- Ep 151 with Dr GPCR Board
Finally, since 2006, they have been the Chief Executive Officer at Montana Molecular, LLC.
- Ep 165 with Chuck DeWeese & Joe St. Germain
The company has been working with startup companies since 2017, serves 25 clients and has assisted over























